by elza | Dec 4, 2020 | News, Oligonucleotides
This interview was originally published in the December issue of CHEManager. Bachem’s Large-Scale Facility to Come Online in 2021 The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf,...
